The Enteric Disease Testing Market was valued at USD 3.80 billion in 2023 and is expected to reach USD 5.25 billion by 2032, growing at a CAGR of 3.70% from 2024-2032.
Our Enteric Disease Testing Market Report provides insights with profound incidence and prevalence analysis, quantifying the worldwide and regional distribution of bacterial, viral, and parasitic diseases. The report contains testing volume trends by geography, illustrating changes in diagnostic adoption among hospitals, laboratories, and research institutions. The report has a market share breakdown by test category, including molecular, immunoassay, and chromatography-based diagnostics. Moreover, we provide comprehensive healthcare expenditure insights region-wise, divided into government, commercial, private, and out-of-pocket expenses. Finally, our study includes regulatory and technology developments such as IVDR compliance, laboratory automation, and AI-based diagnostic advancements.
The U.S. leads the North American Enteric Disease Testing Market with a 3.69% CAGR, with its high disease burden, well-developed healthcare infrastructure, and robust regulatory environment favoring diagnostic innovation. The nation experiences widespread use of molecular and rapid diagnostic tests, fueled by CDC-initiated surveillance programs and growing investments in public health programs.
Drivers
Rising Incidence of Enteric Diseases and Growing Need for Early Diagnosis is accelerating the market growth.
The growing global enteric disease burden, comprising bacterial infections such as Salmonella and Clostridium difficile, viral pathogens such as Norovirus and Rotavirus, and parasitic infections such as Giardia and Cryptosporidium, is a major factor in the enteric disease testing market. Foodborne illnesses claim 48 million people every year in the U.S., as stated by the CDC, triggering more demand for fast and precise diagnostic solutions. Furthermore, food- and waterborne outbreaks have compelled governments to fortify disease surveillance programs. In 2023, the WHO emphasized an upsurge in antimicrobial-resistant (AMR) enteric pathogens, which further boosted demand for molecular diagnostic testing. Vendors such as Cepheid and Roche have broadened their PCR-based panels to promote early and accurate disease detection, fueling market growth.
Advancements in Molecular Diagnostics and Automation in Laboratories are propelling the market to grow.
The transition towards molecular and automation-based diagnostic solutions is transforming enteric disease testing. PCR-based tests, next-generation sequencing (NGS), and multiplex panels offer quicker and more accurate detection than traditional culture techniques. Multiple syndromic panels for the detection of gastrointestinal pathogens have recently been approved by the FDA, boosting the usage of molecular testing in hospitals and diagnostic laboratories. Thermo Fisher Scientific introduced a sophisticated TaqMan Pathogen Detection Kit in 2023, which strengthens real-time PCR capabilities. Diagnostic workflows are also being shortened by automation, decreasing turnaround time and human errors, and increasing efficiency. Greater use of AI-powered diagnostics and automated sample preparation is further simplifying high-throughput enteric disease testing, making it scalable and cost-effective, particularly in areas where disease prevalence is high.
Restraint
High Cost of Advanced Diagnostic Tests and Limited Accessibility in Low-Income Regions are restraining the market from growing.
One of the major constraints in the Enteric Disease Testing Market is the exorbitant price of sophisticated molecular diagnostic tests, which restricts their uptake, especially in low- and middle-income nations (LMICs). Molecular tests like PCR-based assays and next-generation sequencing (NGS) are costly, ranging from USD 50 to USD 300 per test, rendering them less affordable for general disease screening. Furthermore, most of the diagnostic laboratories in developing countries also lack the necessary infrastructure as well as personnel for introducing and sustaining sophisticated diagnostic technologies. A WHO report in 2023 emphasized unequal distribution in enteric disease diagnostics, with low-resource settings continuing to use older culture-based techniques that take longer and are less sensitive compared to newer methods. These barriers to cost and access hamper early diagnosis and control of outbreaks, especially in countries with high disease burden.
Opportunities
The increasing need for quick, convenient, and affordable diagnostic tools is a huge opportunity in the Enteric Disease Testing Market.
Point-of-care (POC) and home-based diagnostic kits enable quicker identification of enteric pathogens without the need for laboratory facilities. Abbott and Meridian Bioscience have launched rapid immunoassay-based stool tests that deliver results in minutes, enhancing early diagnosis and patient care. Further, the growth in telemedicine and online healthcare platforms is fueling the use of at-home testing kits, especially in rural and underserved areas. Decentralized testing will grow substantially by 2030 due to the initiatives of government policies supporting self-testing solutions. The growth of affordable, mobile, and AI-enabled diagnostic tools further supports this market opportunity for industry players.
Challenges
Variability in regulatory standards across regions is challenging the market growth.
One of the significant issues in the Enteric Disease Testing Market is that there are no similar regulatory norms across countries, resulting in time lags for product approvals and market entry obstacles. The European Union's In Vitro Diagnostic Regulation (IVDR 2017/746) replaced earlier directives and has created tighter compliance demands, which hamper manufacturers' launches of new diagnostic products in Europe. The U.S. FDA has rigorous clearance procedures, especially for molecular-based tests, that enhance time-to-market and compliance expenses. Conversely, most developing countries do not have standardized regulations, leading to quality inconsistencies and restricted market reach. The necessity of harmonized global regulatory schemes is still an issue, given that firms will have to deal with complicated approval procedures, affecting innovation and market extension activities in enteric disease diagnosis.
By Disease
The Bacterial Enteric Disease segment dominated the enteric disease testing market with around 54.31% market share in 2023, as a result of the high incidence and extensive outbreaks of bacterial infections like Salmonella, Clostridium difficile, Escherichia coli (E. coli), and Campylobacter. Based on the CDC, Salmonella alone infects around 1.35 million people every year in the U.S., making it a reason for high demand for quick diagnosis testing. Also, HAIs caused by Clostridium difficile (C. difficile) have been on the rise, pushing molecular and immunoassay-based testing solutions. Global governments and healthcare organizations have introduced stringent food safety measures and monitoring initiatives, boosting the uptake of bacterial enteric disease diagnostic tests. The increasing demand for multiplex PCR panels and automated systems from market leaders such as BD, bioMérieux, and Roche has further driven dominance in the segment.
By Test Type
The Immunoassay segment dominated the enteric disease testing market with around 46.32% market share in 2023 because of its prevalence, affordability, and quick turnaround time relative to molecular and traditional diagnostic techniques. Immunoassays, such as enzyme-linked immunosorbent assays (ELISA) and lateral flow assays (LFAs), are used extensively in clinical labs, hospitals, and point-of-care facilities for the detection of enteric pathogens like Salmonella, Clostridium difficile, E. coli, and Rotavirus. Their capacity to provide results in minutes to a few hours makes them crucial for the timely diagnosis and control of outbreaks. Additionally, the increased uptake of immunoassay-based rapid test kits in developing countries, where access to sophisticated molecular diagnostics is constrained, has driven this segment substantially. Organizations such as bioMérieux, Meridian Bioscience, and Abbott have continued to advance highly sensitive immunoassay-based diagnostic products, further establishing the dominance of this test type in 2023.
By End-Use
The Hospitals segment dominated the enteric disease testing market with a 42.11% market share in 2023 because of the large number of patient admissions, sophisticated diagnostic facilities, and growing demand for precise and timely testing. Hospitals are central health facilities for the diagnosis and management of acute gastrointestinal infections, foodborne infections, and hospital-acquired infections (HAIs) like Clostridium difficile (C. difficile). The presence of sophisticated laboratory equipment, skilled personnel, and automated diagnostic platforms in hospitals has fueled the use of enteric disease testing on a large scale, especially molecular diagnostics and immunoassays.
Also, the increase in hospitalization rates of cases due to foodborne outbreaks and infectious diarrhea, along with government efforts for enhancing infection control and patient safety, has further contributed to the growth of hospital-based diagnostic testing. Top players like Roche, Cepheid, and BD have kept expanding hospital-centric diagnostic solutions, confirming the stronghold of the segment in 2023.
North America dominated the Enteric Disease Testing Market with around 38.42% market share in 2023, mostly because it has a well-developed healthcare infrastructure, high disease incidence, and a robust regulatory system. According to the CDC, foodborne illness strikes 48 million Americans every year, fueling demand for fast and reliable diagnostic solutions. The area boasts a strong adoption of molecular diagnostics and automation-driven laboratory processes, with prominent companies such as Cepheid, Roche, and Abbott continually developing next-generation PCR-based and syndromic panel tests. Furthermore, government policies and funding initiatives, including the FDA's antimicrobial resistance (AMR) surveillance efforts and the U.S. Food Safety Modernization Act (FSMA), have fortified the area's diagnostic infrastructure. The availability of major biotechnology companies and reference labs, as well as extensive insurance coverage for diagnostic procedures, further cements North America's leadership in this market.
Asia Pacific is the fastest-growing region in the enteric disease testing market with a 4.25% CAGR throughout the forecast period, fueled by growing disease incidence, urbanization, and enhanced accessibility to healthcare. India, China, and Indonesia have a high rate of bacterial and viral enteric infections because of poor sanitation, dirty water sources, and weak food safety control. The WHO approximates that more than 220 million children are affected by diarrheal diseases every year in Asia, and this demonstrates the need for effective diagnostic products. Furthermore, efforts by the government to enhance infectious disease surveillance, coupled with increasing investments in healthcare infrastructure and growing diagnostic laboratory networks, are driving market growth. The rising use of point-of-care and low-cost rapid test kits, backed by local players and multinational corporations, further enhances the region's diagnostic testing growth and accessibility.
Abbott Laboratories (RealTime PCR Assays, Immunoassay Kits)
Becton, Dickinson and Company (BD) (BD MAX Enteric Bacterial Panel, BD Veritor System)
Biomerica, Inc. (EZ Detect Stool Blood Test, H. pylori Test)
bioMérieux SA (VIDAS Enteric Panel, GENE-UP Pathogen Detection)
Bio-Rad Laboratories, Inc. (iQ-Check Real-Time PCR Kits, Bio-Plex Multiplex Immunoassays)
Cepheid (Danaher Corporation) (Xpert C. difficile, Xpert Norovirus)
Coris BioConcept (Gastro Viruses Respi-Strip, H. pylori Antigen Test)
DiaSorin S.p.A. (LIAISON Enteric Pathogen Panel, Simplexa C. difficile Direct)
Meridian Bioscience, Inc. (ImmunoCard STAT! EHEC, Premier C. difficile GDH)
Quest Diagnostics (GI Pathogen Panel, H. pylori Urea Breath Test)
Trinity Biotech (Uni-Gold H. pylori, EntericBio Multiplex PCR)
Thermo Fisher Scientific (TaqMan Pathogen Detection Kits, SureTect PCR Assays)
Quansys Biosciences Inc. (Q-Plex Human Environmental Enteric Dysfunction Panel, Q-Plex Multiplex ELISA Kits)
SGS (Microbiological Testing Services, Pathogen Detection Assays)
Merck (Singlepath Listeria, Singlepath Salmonella)
Roche Diagnostics (LightCycler PCR Systems, cobas Cdiff Test)
GenMark Diagnostics (ePlex Gastrointestinal Pathogen Panel, eSensor Respiratory Viral Panel)
Luminex Corporation (VERIGENE Enteric Pathogens Test, xTAG Gastrointestinal Pathogen Panel)
Hologic, Inc. (Aptima GI Assays, Panther Fusion GI Panel)
Siemens Healthineers (IMMULITE 2000 Immunoassay System, VERSANT kPCR Molecular System)
Suppliers (These suppliers commonly provide essential reagents and consumables, such as enzymes, nucleotides, and buffers, which are crucial for developing and performing diagnostic assays used in enteric disease testing). In the enteric disease testing market.
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Qiagen N.V.
PerkinElmer Inc.
Agilent Technologies
Promega Corporation
Takara Bio Inc.
New England Biolabs
Integrated DNA Technologies (IDT)
In Feb. 2025 – Biomerica, Inc., a leading international company for medical diagnostic products, has issued a statement stating that its products for food intolerance used for the diagnosis of Crohn's Disease and Ulcerative Colitis have been certified CE-mark as per the European Union's revised In Vitro Diagnostic Medical Devices Regulation (IVDR – 2017/746).
In April 2023, Danaher-owned Cepheid is soon to launch several new infectious disease diagnostic tests, including those for tuberculosis and respiratory viruses, as part of its long-term commitment to molecular diagnostics innovation.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 3.80 billion |
| Market Size by 2032 | US$ 5.25 billion |
| CAGR | CAGR of 3.70% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Disease (Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease) • By Test Type (Immunoassay, Molecular, Conventional, Chromatography & Spectrometry, Other Test Types) • By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Institutes, Other End-users) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott Laboratories, Becton, Dickinson and Company (BD), Biomerica, Inc., bioMérieux SA, Bio-Rad Laboratories, Cepheid (Danaher Corporation), Coris BioConcept, DiaSorin S.p.A., Meridian Bioscience, Inc., Quest Diagnostics, Trinity Biotech, Thermo Fisher Scientific, Quansys Biosciences Inc., SGS, Merck, Roche Diagnostics, GenMark Diagnostics, Luminex Corporation, Hologic, Inc., Siemens Healthineers, and other players. |
Ans: The Enteric Disease Testing Market is expected to grow at a CAGR of 3.70% from 2024-2032.
Ans: The Enteric Disease Testing Market was USD 3.80 billion in 2023 and is expected to reach USD 5.25 billion by 2032.
Ans: Advancements in Molecular Diagnostics and Automation in Laboratories are propelling the market to grow.
Ans: The “Bacterial enteric disease” segment dominated the Enteric Disease Testing Market.
Ans: North America dominated the Enteric Disease Testing Market in 2023.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Testing Volume and Trends, by Region (2023-2032)
5.3 Market Share by Test Type (2023-2032).
5.4 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket) (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Enteric Disease Testing Market Segmentation, By Disease
7.1 Chapter Overview
7.2 Bacterial enteric disease
7.2.1 Bacterial Enteric Disease Market Trends Analysis (2020-2032)
7.2.2 Bacterial Enteric Disease Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 C. difficile
7.2.3.1 C. difficile Market Trends Analysis (2020-2032)
7.2.3.2 C. difficile Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 E. coli
7.2.4.1 E. coli Market Trends Analysis (2020-2032)
7.2.4.2 E. coli Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Salmonella
7.2.5.1 Salmonella Market Trends Analysis (2020-2032)
7.2.5.2 Salmonella Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Campylobacter
7.2.6.1 Campylobacter Market Trends Analysis (2020-2032)
7.2.6.2 Campylobacter Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Listeria
7.2.7.1 Listeria Market Trends Analysis (2020-2032)
7.2.7.2 Listeria Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.8 Shigellosis
7.2.8.1 Shigellosis Market Trends Analysis (2020-2032)
7.2.8.2 Shigellosis Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Viral enteric disease
7.3.1 Viral Enteric Disease Market Trends Analysis (2020-2032)
7.3.2 Viral Enteric Disease Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Rotavirus infection
7.3.3.1 Rotavirus infection Market Trends Analysis (2020-2032)
7.3.3.2 Rotavirus infection Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Norovirus infection
7.3.4.1 Norovirus infection Market Trends Analysis (2020-2032)
7.3.4.2 Norovirus infection Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Parasitic enteric disease
7.4.1 Parasitic Enteric Disease Market Trends Analysis (2020-2032)
7.4.2 Parasitic Enteric Disease Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.3 Giardiasis
7.4.3.1 Giardiasis Market Trends Analysis (2020-2032)
7.4.3.2 Giardiasis Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.4 Amebiasis
7.4.4.1 Amebiasis Market Trends Analysis (2020-2032)
7.4.4.2 Amebiasis Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.5 Cryptosporidiosis
7.4.5.1 Cryptosporidiosis Market Trends Analysis (2020-2032)
7.4.5.2 Cryptosporidiosis Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Enteric Disease Testing Market Segmentation, By Test Type
8.1 Chapter Overview
8.2 Immunoassay
8.2.1 Immunoassay Market Trends Analysis (2020-2032)
8.2.2 Immunoassay Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Molecular
8.3.1 Molecular Market Trends Analysis (2020-2032)
8.3.2 Molecular Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Conventional
8.4.1 Conventional Market Trends Analysis (2020-2032)
8.4.2 Conventional Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Chromatography & spectrometry
8.5.1 Chromatography & Spectrometry Market Trends Analysis (2020-2032)
8.5.2 Chromatography & Spectrometry Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Other test types
8.6.1 Other test types Market Trends Analysis (2020-2032)
8.6.2 Other test types Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Enteric Disease Testing Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Diagnostic laboratories
9.3.1 Diagnostic laboratories Market Trends Analysis (2020-2032)
9.3.2 Diagnostic laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Research & academic institutes
9.4.1 Research & academic institutes Market Trends Analysis (2020-2032)
9.4.2 Research & academic institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Other end-users
9.5.1 Other end-users Market Trends Analysis (2020-2032)
9.5.2 Other end-users Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.2.4 North America Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.5 North America Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.2.6.2 USA Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.6.3 USA Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.2.7.2 Canada Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.7.3 Canada Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.2.8.2 Mexico Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.8.3 Mexico Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.1.6.2 Poland Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.6.3 Poland Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.1.7.2 Romania Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.7.3 Romania Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.4 Western Europe Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.5 Western Europe Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.6.2 Germany Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.6.3 Germany Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.7.2 France Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.7.3 France Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.8.2 UK Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.8.3 UK Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.9.2 Italy Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.9.3 Italy Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.10.2 Spain Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.10.3 Spain Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.13.2 Austria Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.13.3 Austria Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.4 Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.5 Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.6.2 China Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.6.3 China Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.7.2 India Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.7.3 India Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.8.2 Japan Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.8.3 Japan Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.9.2 South Korea Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.9.3 South Korea Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.10.2 Vietnam Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.10.3 Vietnam Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.11.2 Singapore Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.11.3 Singapore Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.12.2 Australia Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.12.3 Australia Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.1.4 Middle East Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.5 Middle East Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.1.6.2 UAE Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.6.3 UAE Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.2.4 Africa Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.5 Africa Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Enteric Disease Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.6.4 Latin America Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.5 Latin America Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.6.6.2 Brazil Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.6.3 Brazil Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.6.7.2 Argentina Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.7.3 Argentina Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.6.8.2 Colombia Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.8.3 Colombia Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Enteric Disease Testing Market Estimates and Forecasts, by Disease (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Enteric Disease Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Enteric Disease Testing Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Becton, Dickinson and Company
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Biomerica, Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 bioMérieux SA
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Cepheid
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Coris BioConcept
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 DiaSorin S.p.A.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Meridian Bioscience, Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Quest Diagnostics
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Enteric Disease Testing Market Key Segments:
By Disease
Bacterial enteric disease
C. difficile
E. coli
Salmonella
Campylobacter
Listeria
Shigellosis
Viral enteric disease
Rotavirus infection
Norovirus infection
Parasitic enteric disease
Giardiasis
Amebiasis
Cryptosporidiosis
By Test Type
Immunoassay
Molecular
Conventional
Chromatography & spectrometry
Other test types
By End-Use
Hospitals
Diagnostic laboratories
Research & academic institutes
Other end-users
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Mass Spectrometry in Precision Medicine Market is growing significantly and is expected to expand at a CAGR of around 8.01% from 2024-2032.
The Intraoral Scanners Market valued USD 0.67 billion in 2023, estimated to reach USD 1.23 Billion By 2032 with a CAGR of 6.99% over the forecast period 2024-2032.
The Clinical Microbiology Market was valued at USD 4.3 billion in 2023 and is expected to reach USD 7.4 billion by 2032 and grow at a CAGR of 5.9% over the forecast period 2024-2032.
The Medical Decision Support Systems for Sepsis Market size was valued at USD 45.10 million in 2023, and is expected to reach USD 328.83 million by 2032, and grow at a CAGR of 24.70% over the forecast period 2024-2032.
The Cell Therapy Human Raw Materials Market Size was valued at USD 2.9 Bn in 2023 and will reach $18.1 Bn by 2032 and grow at a CAGR of 22.6% by 2024-2032.
The Angiography Equipment Market Size was valued at USD 10.53 Billion in 2023 and is expected to reach USD 17.92 Billion by 2032 and grow at a CAGR of 6.11% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
